Investigating the effect of Zinc-Sulfate on the Treatment of Neonatal Hyperbilirubinemia
Phase 3
Recruiting
- Conditions
- eonatal Hyperbilirubinemia.Neonatal jaundice due to other excessive hemolysis
- Registration Number
- IRCT20220806055625N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Term infants with hyperbilirubinemia admitted to the neonatal department of Besat Sanandaj Hospital in 1401
Gestational age from 37 weeks to 42 weeks and 6 days
Birth weight from 2500 Grams to 4000 Grams
Exclusion Criteria
Evidence of infection
Congenital malformation
History of phenobarbital use in mother
Hypothyroidism
Inappropriate intrauterine growth
Oral intolerance
Mechanical ventilation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method